Home > Travel > Asia > China > Beijing

Current status and regulatory perspective of chimeric antigen receptor-modified T cell therapeutics by Mi-Gyeong Kim & Dongyoon Kim & Soo-Kyung Suh & Zewon Park & Min Joung Choi & Yu-Kyoung Oh

Author:Mi-Gyeong Kim & Dongyoon Kim & Soo-Kyung Suh & Zewon Park & Min Joung Choi & Yu-Kyoung Oh , Date: February 19, 2022 ,Views: 18

Current status and regulatory perspective of chimeric antigen receptor-modified T cell therapeutics by Mi-Gyeong Kim & Dongyoon Kim & Soo-Kyung Suh & Zewon Park & Min Joung Choi & Yu-Kyoung Oh

Author:Mi-Gyeong Kim & Dongyoon Kim & Soo-Kyung Suh & Zewon Park & Min Joung Choi & Yu-Kyoung Oh
Format: pdf
Tags: Chimeric antigen receptor-modified T cells; Clinical trials; Manufacture; Safety; Efficacy; Regulatory perspective
Publisher: Pharmaceutical Society of Korea
Published: 2016-02-17T09:52:15+00:00


Download

Current status and regulatory perspective of chimeric antigen receptor-modified T cell therapeutics by Mi-Gyeong Kim & Dongyoon Kim & Soo-Kyung Suh & Zewon Park & Min Joung Choi & Yu-Kyoung Oh.pdf


Copyright Disclaimer:
This site does not store any files on its server. We only index and link to content provided by other sites. Please contact the content providers to delete copyright contents if any and email us, we'll remove relevant links or contents immediately.